BAT CEO Warns Disposable E-Cigarette Ban Will Backfire

BAT by 2FIRSTS, edited by Sophia
Mar.26.2024
BAT CEO Warns Disposable E-Cigarette Ban Will Backfire
BAT CEO Tadeu Marroco believes the UK government's plan to ban disposable e-cigarettes will have unintended consequences.

According to a report by the BBC on March 25, Tadeu Marroco, the CEO of British American Tobacco (BAT), stated that banning disposable e-cigarettes would not be effective and that raising the smoking age limit would have "unintended consequences.

 

The British government plans to ban the sale of disposable e-cigarettes starting in April of next year, in what is being touted as the biggest public health measure in decades. Currently, BAT is the third largest e-cigarette sales company in the UK. Sales of disposable e-cigarettes have surged in recent years, with projections indicating that annual sales could reach into the billions, many of which are being sold illegally.

 

The British government announced a tobacco and e-cigarette law last week, which will prohibit individuals born after 2009 from purchasing tobacco and impose on-the-spot fines for retailers selling to those under 18.

 

However, Maroko stated that similar bans in other countries have not achieved the desired results. He said:

 

In other countries, the effectiveness of this policy is not ideal. In Australia, for example, a complete ban has led to high levels of purchases by teenagers in the illegal market, and Brazil has experienced a similar situation.

 

Deborah Arnott, Chief Executive of the anti-smoking charity organization Action on Smoking and Health (ASH), has expressed opposition to the ban on disposable products, stating that while it is feasible, strict regulation is necessary not only within shops but also to prevent illegal imports.

 

BAT, one of the largest publicly traded companies in the UK, ranks third in the disposable e-cigarette market. Chinese companies SKE and Heaven Gifts are the market leaders, manufacturing e-cigarette products including ELFBAR and Lost Mary.

 

Maroko agreed that stricter punishment measures are needed. He stated that the proposed on-the-spot fine of £100 "is not enough" and called for the implementation of France's proposed €100,000 (approximately £86,000) "appropriate fine".

 

However, he issued a warning against the government's plan to raise the legal smoking age limit each year, stating that those born in 2009 and later will never be able to legally purchase tobacco, which will have "unintended consequences" for retail and enforcement.

 

"We first need to address the issue of minors using e-cigarettes. We need to have retail licenses, just like we do for alcohol products," he reiterated the company's call to ban flavors that appeal to children, such as dessert and soft drink flavors.

 

When asked whether BAT only supports policies that align with the company's interests, the CEO replied, "This is an industry that has been under close scrutiny on how to reduce the impact of our products on health... This is the first time we have the technology to do this."

 

Mr. Marlboro defended the company's sponsorship activities, stating that they were "primarily targeted at adults" as they distributed free samples of their oral nicotine pouch products for promotional purposes. "We are very careful about this," he said. The UK Tobacco and E-cigarette Act will grant the government the power to regulate the sale of nicotine pouches.

 

When asked if the company has a say in regulating e-cigarettes, Mr. Maloco did not comment, but he said, "We have already discussed these issues in detail in the past, and they are now in the past...BAT now has the opportunity to reduce the risks of our products, which was not possible in the past."

 

Mrs. Arnot from ASH stated:

 

We have heard BAT say many times that they have changed, but BAT is still promoting traditional tobacco cigarettes...most of their profits still come from this. This is why they don't like government sales age legislation, not because it is ineffective, but because it is effective.

 

In a statement, the Department of Health and Social Care stated that approximately 80,000 people in the UK die from smoking each year, leading to a loss of £17 billion annually. The Tobacco and E-cigarette Bill is the largest public health measure in recent decades, aiming to protect future generations from the harm of smoking. It is expected to save thousands of lives and billions of pounds for our National Health Service, freeing up new resources to improve the overall health of the UK.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

GSTHR Estimates 200 Million People Use Non-Combustible Nicotine Products as 28 Countries Show Rising Use Alongside Falling Smoking Rates
GSTHR Estimates 200 Million People Use Non-Combustible Nicotine Products as 28 Countries Show Rising Use Alongside Falling Smoking Rates
The Global State of Tobacco Harm Reduction, a project operated by Knowledge·Action·Change, estimates that about 200 million people worldwide use non-combustible nicotine products including vapes, heated tobacco, nicotine pouches and snus. Its 2026 report says use of these products rose alongside declining smoking rates in 28 countries it analyzed. The data do not establish that all 200 million users have quit smoking, nor do they prove a direct causal relationship. GSTHR also says regulatory restrictions on the products continue to expand in many markets.
Sep.10
As Regulators Focus on Nicotine Pouch Child Safety, Safeguard Pursues an External Packaging Route
As Regulators Focus on Nicotine Pouch Child Safety, Safeguard Pursues an External Packaging Route
As regulators pay closer attention to child safety in nicotine pouches, manufacturers face a practical challenge: how to strengthen child-resistant packaging without unnecessarily reworking products, production lines and regulatory submissions already in place. In a written interview with 2Firsts, Chemular detailed Safeguard’s external packaging approach, its customer-specific testing requirements and possible PMTA pathways. The model remains early-stage, but it offers a new way to think about an increasingly important regulatory and manufacturing issue.
Industry Insight
Sep.19
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
GAO Audit Finds Nearly 132,000 FDA Tobacco Applications Waiting an Average 1,266 Days as Nicotine Pouch Pilot Practices Move Into Vape PMTA Reviews
GAO Audit Finds Nearly 132,000 FDA Tobacco Applications Waiting an Average 1,266 Days as Nicotine Pouch Pilot Practices Move Into Vape PMTA Reviews
A U.S. Government Accountability Office audit found that 131,915 tobacco product applications submitted to the FDA since 2018 remained without a final review as of December 31, 2025, with pending applications waiting an average of 1,266 days. GAO also found FDA lacks the data needed to systematically determine whether scientific reviews meet applicable timelines. HHS agreed to upgrade the agency's tracking systems. At the same time, FDA has begun applying lessons from its nicotine pouch PMTA pilot to e-cigarette reviews, while changes to enforcement policy and electronic submissions are making the specific stage of a PMTA increasingly relevant to market access.
FDA
Oct.03
JTI Liggett Puts U.S. Value Cigarette Brands in Spotlight at 2026 NACS Show
JTI Liggett Puts U.S. Value Cigarette Brands in Spotlight at 2026 NACS Show
At the 2026 NACS Show in Las Vegas, JTI Liggett highlighted its value-priced cigarette portfolio, including LD and Montego, following JT Group's acquisition of Vector Group. The company's U.S. business reported market share gains, with LD sales volume rising 32.6% in the first half of 2026. Meanwhile, Ploom was displayed separately at Altria's booth under an existing partnership. JTI Liggett booth staff told 2Firsts that the company had not yet launched nicotine pouch products in the United States.
EXPO
Oct.09
Special Report|From CrossBar 20K to 6-Methyl Nicotine KUMI: Two Routes Into U.S. State Vape Directories?
Special Report|From CrossBar 20K to 6-Methyl Nicotine KUMI: Two Routes Into U.S. State Vape Directories?
Several U.S. states have incorporated the September 9, 2020 PMTA filing deadline into eligibility rules for certain vaping products. CrossBar 20K drew attention after appearing on Pennsylvania's 163-entry directory. A broader 2Firsts investigation found that related registration businesses also listed KUMI and CROSSBAR SIX products, with 171 KUMI-related entries across Louisiana, Nebraska and Wisconsin. Corporate records link Scott Silverman to Blue Nine LLC and VR Products I LLC. PMTA compliance expert Mr. K said historical applications and nicotine-analogue products may offer two different approaches to state-directory access.
Regulations
Oct.26